KLBF - Kalbe Farma Tbk. | KLBF - Kalbe Farma Tbk. | KLBF - Kalbe Farma Tbk. | ||
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (22) | : | IDX30, IDXLQ45LCL, ESGS KEHATI, IDXHIDIV20, IDXG30, COMPOSITE, IDXHEALTH, MBX, ESGSKEHATI, IDXSHAGROW, ESGQ KEHATI, KOMPAS100, BISNIS-27, ISSI, Investor33, SRI-KEHATI, IDXQ30, JII70, JII, IDX80, LQ45, ESGQKEHATI | ||
Index (22) | : | IDX30, IDXLQ45LCL, ESGS KEHATI, IDXHIDIV20, IDXG30, COMPOSITE, IDXHEALTH, MBX, ESGSKEHATI, IDXSHAGROW, ESGQ KEHATI, KOMPAS100, BISNIS-27, ISSI, Investor33, SRI-KEHATI, IDXQ30, JII70, JII, IDX80, LQ45, ESGQKEHATI | ||
Board | : | 22 Index IDX30, IDXLQ45LCL, ESGS KEHATI, IDXHIDIV20, IDXG30, COMPOSITE, IDXHEALTH, MBX, ESGSKEHATI, IDXSHAGROW, ESGQ KEHATI, KOMPAS100, BISNIS-27, ISSI, Investor33, SRI-KEHATI, IDXQ30, JII70, JII, IDX80, LQ45, ESGQKEHATI | ||
Fasilitas Marjin | : | Saham yang bisa diperdagangkan dengan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ||||||
F Poor | ||||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING FUNDAMENTAL | ||
---|---|---|
Rating EPS | 4 | |
Rating ROA | 3 | |
Rating EQUITY | 2 | |
Rating ROE | 2 | |
Rating DER | 2 | |
Rating TOTAL | 4 |
MARKET CAPITALIZATION | ||
Listed Share | 46.875.122.110 | |
Price | Rp. 1.445 | |
Capitalization | Rp. 67.734.551.448.950 | |
OWNERSHIP | ||
Listing Date : | ||
Lokal 73,59 % | Asing 26,25 % | Lainnya 0,16 % |
KLBF - Kalbe Farma Tbk. | KLBF - Kalbe Farma Tbk. | KLBF - Kalbe Farma Tbk. | ||
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (22) | : | IDX30, IDXLQ45LCL, ESGS KEHATI, IDXHIDIV20, IDXG30, COMPOSITE, IDXHEALTH, MBX, ESGSKEHATI, IDXSHAGROW, ESGQ KEHATI, KOMPAS100, BISNIS-27, ISSI, Investor33, SRI-KEHATI, IDXQ30, JII70, JII, IDX80, LQ45, ESGQKEHATI | ||
Index (22) | : | IDX30, IDXLQ45LCL, ESGS KEHATI, IDXHIDIV20, IDXG30, COMPOSITE, IDXHEALTH, MBX, ESGSKEHATI, IDXSHAGROW, ESGQ KEHATI, KOMPAS100, BISNIS-27, ISSI, Investor33, SRI-KEHATI, IDXQ30, JII70, JII, IDX80, LQ45, ESGQKEHATI | ||
Board | : | 22 Index IDX30, IDXLQ45LCL, ESGS KEHATI, IDXHIDIV20, IDXG30, COMPOSITE, IDXHEALTH, MBX, ESGSKEHATI, IDXSHAGROW, ESGQ KEHATI, KOMPAS100, BISNIS-27, ISSI, Investor33, SRI-KEHATI, IDXQ30, JII70, JII, IDX80, LQ45, ESGQKEHATI | ||
Fasilitas Marjin | : | Saham yang bisa diperdagangkan dengan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
Description | 3Q18 | 3Q19 | 3Q20 | 3Q21 | 3Q22 | 3Q23 | 3Q24 | CAGR 5Y(%) |
Last Price | 1380 | 1675 | 1550 | 1430 | 1830 | 1755 | 1615 | |
Market Cap | 64.7 T | 78.5 T | 72.7 T | 67.0 T | 85.8 T | 82.3 T | 75.7 T | -3.57 |
BALANCE SHEET | ||||||||
Cash | 2.5 T | 2.6 T | 4.4 T | 5.6 T | 4.1 T | 2.8 T | 4.2 T | 61.54 |
Total Asset | 17.5 T | 19.6 T | 22.5 T | 24.3 T | 26.2 T | 27.2 T | 28.8 T | 46.94 |
S.T.Borrowing | 2.4 T | 2.6 T | 3.4 T | 3.3 T | 4.3 T | 4.2 T | 4.1 T | |
L.T.Borrowing | 525.3 B | 906.2 B | 1.2 T | 949.9 B | 785.1 B | 629.4 B | 735.3 B | |
Total Equity | 14.6 T | 16.1 T | 17.9 T | 20.0 T | 21.1 T | 22.4 T | 23.9 T | 48.45 |
INCOME STATEMENT | ||||||||
Revenue | 15.7 T | 16.8 T | 17.1 T | 19.1 T | 21.2 T | 22.6 T | 24.2 T | 44.05 |
Gross Profit | 7.5 T | 7.8 T | 7.8 T | 8.3 T | 8.7 T | 8.9 T | 9.5 T | 21.79 |
Operating Profit | 2.6 T | 2.7 T | 2.7 T | 3.1 T | 3.3 T | 3.0 T | 3.3 T | 22.22 |
Net.Profit | 1.8 T | 1.9 T | 2.0 T | 2.3 T | 2.5 T | 2.1 T | 2.4 T | 26.32 |
EBITDA | 2.8 T | 2.9 T | 3.0 T | 3.3 T | 3.6 T | 3.3 T | 3.6 T | 24.14 |
Interest Expense | 22.1 B | 27.5 B | 67.4 B | 43.9 B | 35.1 B | 76.6 B | 50.5 B | |
RATIO | ||||||||
EPS | 38.47 | 40.84 | 43.23 | 48.78 | 53 | 44.03 | 50.71 | 24.17 |
PER | 35.87 x | 41.01 x | 35.85 x | 29.32 x | 34.53 x | 39.86 x | 31.85 x | |
BVPS | 311 | 344.23 | 381.92 | 426.49 | 451.17 | 477.31 | 510.12 | |
PBV | 4.44 x | 4.87 x | 4.06 x | 3.35 x | 4.06 x | 3.68 x | 3.17 x | |
ROA | 0.1029 | 0.0978 | 0.0903 | 0.0943 | 0.0949 | 0.076 | 0.0827 | -15.44 |
ROE | 0.1238 | 0.1187 | 0.1132 | 0.1144 | 0.1175 | 0.0923 | 0.0995 | -16.18 |
EV/EBITDA | 23.25 | 27.2 | 24.39 | 19.62 | 24.03 | 25.73 | 21.07 | |
Debt/Equity | 0.2 | 0.21 | 0.25 | 0.21 | 0.24 | 0.21 | 0.2 | |
Debt/TotalCap | 0.17 | 0.18 | 0.2 | 0.18 | 0.19 | 0.18 | 0.17 | |
Debt/EBITDA | 1.05 | 1.19 | 1.52 | 1.28 | 1.4 | 1.47 | 1.34 | |
EBITDA/IntExps | 126.49 | 106 | 44.27 | 76.3 | 102.78 | 42.77 | 71.8 | -32.26 |
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ||||||
F Poor | ||||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
MARKET CAPITALIZATION | ||
Listed Share | 46.875.122.110 | |
Price | Rp. 1.445 | |
Capitalization | Rp. 67.735 B. | |
OWNERSHIP | ||
Listing Date : | ||
Lokal 73,59 % | Asing 26,25 % | Lainnya 0,16 % |
RATING FUNDAMENTAL | ||
---|---|---|
Rating EPS | 4 | |
Rating ROA | 3 | |
Rating EQUITY | 2 | |
Rating ROE | 2 | |
Rating DER | 2 | |
Rating TOTAL | 4 |
KLBF - Kalbe Farma Tbk. | KLBF - Kalbe Farma Tbk. | KLBF - Kalbe Farma Tbk. | ||
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (22) | : | IDX30, IDXLQ45LCL, ESGS KEHATI, IDXHIDIV20, IDXG30, COMPOSITE, IDXHEALTH, MBX, ESGSKEHATI, IDXSHAGROW, ESGQ KEHATI, KOMPAS100, BISNIS-27, ISSI, Investor33, SRI-KEHATI, IDXQ30, JII70, JII, IDX80, LQ45, ESGQKEHATI | ||
Index (22) | : | IDX30, IDXLQ45LCL, ESGS KEHATI, IDXHIDIV20, IDXG30, COMPOSITE, IDXHEALTH, MBX, ESGSKEHATI, IDXSHAGROW, ESGQ KEHATI, KOMPAS100, BISNIS-27, ISSI, Investor33, SRI-KEHATI, IDXQ30, JII70, JII, IDX80, LQ45, ESGQKEHATI | ||
Board | : | 22 Index IDX30, IDXLQ45LCL, ESGS KEHATI, IDXHIDIV20, IDXG30, COMPOSITE, IDXHEALTH, MBX, ESGSKEHATI, IDXSHAGROW, ESGQ KEHATI, KOMPAS100, BISNIS-27, ISSI, Investor33, SRI-KEHATI, IDXQ30, JII70, JII, IDX80, LQ45, ESGQKEHATI | ||
Fasilitas Marjin | : | Saham yang bisa diperdagangkan dengan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
TIME PERIOD : 13-12-2024 | |||
Close | 1445 | Prev Close | 1455 |
Change | -10 (-0.7%) | Range | 1430-1465 |
Bid | 1440 | Offer | 1445 |
Bid Volume | 100 | Offer Volume | 712800 |
Frequency | 2024 | Value Rp.: 44.027.747.000 |
EARNING PER SHARE (% PRICE) | |||||
---|---|---|---|---|---|
Benchmark to Others : | |||||
A Exceptional | |||||
B Excellent | |||||
C Very Good | |||||
D Good | |||||
E Fair | |||||
F Poor | |||||
Percent (%) of Price |
≤ 0 |
0-1.05 | 1.05-2.3 | 2.3-4.23 | > 4.23 |
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ||||||
F Poor | ||||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |